# Gyre Therapeutics, Inc.: Form SC 13D, filed Sep 6, 2024

- Company: [Gyre Therapeutics, Inc.](/companies/gyre.md) (CIK 1124105)
- Form: SC 13D
- Filed: 2024-09-06
- Accepted by EDGAR: Sep 6, 2024, 08:31 ET
- Period: not reported
- Accession: 0001140361-24-040318
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1124105/000114036124040318/ef20035609_sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1124105/000114036124040318/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1124105/000114036124040318/ef20035609_sc13d.htm

Filed Sep 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-040318. Last ingested by Listed: Nov 5, 2026, 18:44 ET. No prices; not investment advice.